Study Results
Outcome measurements, participant flow, baseline characteristics, and adverse events have been published for this study.
View full resultsBasic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
122 participants
INTERVENTIONAL
2020-01-02
2024-02-09
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Intervention for IPV Perinatal Women- RCT
NCT02370394
Violence Prevention for Middle School Boys
NCT03109184
Can Safety Planning Improve Perinatal Outcomes Among Pregnant Women Exposed to Intimate Partner Violence?
NCT00831831
Strength at Home Couples Program (PTSD-Focused Relationship Enhancement Therapy for Returning Veterans)
NCT00827879
Trauma-Informed Peer Aggression and Dating Violence Prevention for Preteens Receiving Intensive Mental Health Services
NCT06769282
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
The objective of this R01 Award is to fill this critical gap by building upon our promising pilot findings to test whether the innovative intervention, "Strength for U in Relationship Empowerment" (SURE), reduces the frequency of IPV more than an attention, time, and information matched control condition in perinatal women seeking mental health care.
The investigators propose a two-group, randomized controlled trial in which 186 perinatal women with IPV women seeking mental health care who will be assigned to either (a) SURE, a computer-delivered, single-session brief intervention plus one interventionist-led phone booster that is consistent with motivational interviewing and informed by the literature on effective interventions for our target population and targeted risk factors, or (b) a computer-delivered control + one interventionist-led phone booster condition. Computer-delivered follow-up assessments will occur at 6 weeks, 3 months, 6 months, and 12 months after the baseline assessment.
Anticipated 25% of planned enrollment recruited by 5/14/2021. Anticipated 50% of planned enrollment recruited by 2/15/2022. Anticipated 75% of planned enrollment recruited by 8/15/2022. Anticipated 100% of planned enrollment recruited by 2/13/2023. Anticipated completion of primary endpoints data analyses by 6/28/2024. Anticipated reporting of results in ClinicalTrials.gov by 6/30/2025.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
PREVENTION
SINGLE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Strength for U in Relationship Empowerment (SURE)
Theory-driven and derived from empirical support
Strength for U in Relationship Empowerment (SURE)
A brief computer-based intervention (one session plus one booster session) based on motivational interviewing.
Attention, time, and information matched control
Well-validated
Attention, time, and information matched control
A brief computer based intervention (one session plus booster session) that involves viewing of popular television shows
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Strength for U in Relationship Empowerment (SURE)
A brief computer-based intervention (one session plus one booster session) based on motivational interviewing.
Attention, time, and information matched control
A brief computer based intervention (one session plus booster session) that involves viewing of popular television shows
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
2. Women who have had a baby in the last 12 months
3. Between the ages of 18-45 years old
4. Have reported partner abuse within the last year as measured by the Woman Abuse Screening Tool (WAST)
5. Have sought mental health treatment
Exclusion Criteria
2. Unable to understand English
3. No access to the internet or a device with internet access
4. Discomfort with internet use
5. No privacy to view a 40-minute online intervention
6. Screen positive for risk of intimate partner violence that involves severe injury or homicide
7. Screen positive for risk of spyware/stalkerware
8. At one of the two research site, study recruit is unwilling to meet for in-person study visits (if criteria 3-8 are met)
18 Years
45 Years
FEMALE
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)
NIH
Women and Infants Hospital of Rhode Island
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Caron Zlotnick
Professor of Psychiatry and Human Behavior, Professor of Obstetrics and Gynecology, Professor of Medicine
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Caron Zlotnick, PhD
Role: PRINCIPAL_INVESTIGATOR
Women and Infants Hospital
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Women and Infants Hospital of Rhode Island
Providence, Rhode Island, United States
Countries
Review the countries where the study has at least one active or historical site.
Provided Documents
Download supplemental materials such as informed consent forms, study protocols, or participant manuals.
Document Type: Study Protocol and Statistical Analysis Plan
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
166275
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.